ArcticZymes Technologies announces CEO resignation
Tromsø, March 22nd 2023 – ArcticZymes Technologies ASA (OSE: AZT) announces that the Board of Directors has today accepted the voluntary resignation of Jethro Holter as Chief Executive Officer, due to personal reasons.
The resignation will take effect on 30th September 2023 after the required 6 months notice period.
“On behalf of the Board, I want to thank Jethro very much for his outstanding contributions to ArcticZymes over the past 3 years that he has served as our CEO. During that time, Jethro has been instrumental in transforming ArcticZymes into a successful and highly profitable business,” said Marie Roskrow. “All of the employees of ArcticZymes send their good wishes and thanks to Jethro.”
The Board of Directors will immediately initiate a search for a new CEO. In the meantime, Chairman of the Board, Marie Roskrow, will act as Executive Chairman to lead and support the Company through this transition period.
ArcticZymes also anticipates expanding the Board of Directors in the near future.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
The announcement was submitted for publication by Børge Sørvoll ,CFO at ArcticZymes Technologies ASA, on 22 March 2023 at 10:20 CET.
For more information, please contact:
ArcticZymes Technologies | |
Chairman of the Board, Marie Roskrow | Tel: +44 (0) 7496 959 743 marie.roskrow@arcticzymes.com |
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the development, manufacturing and commercialization of novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.
The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes Technologies under the [AZT] ticker. Its headquarters are based in Tromsø, Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies’ IP and capabilities are protected via a large portfolio of patents.
For more information, please visit the website: www.arcticzymes.com.